Evidence map›Paper›PMID 36217596›Full record

ReviewKorean circulation journal2022

Pharmacological Approaches to Limit Ischemic and Reperfusion Injuries of the Heart: Analysis of Experimental and Clinical Data on P2Y

Leonid N Maslov, Sergey V Popov, Alexandr V Mukhomedzyanov, Ivan A Derkachev, Vyacheslav V Ryabov, Alla A Boshchenko, N Rajendra Prasad, Galina Z Sufianova, Maria S Khlestkina, Ilgiz Gareev

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Korean circulation journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Leonid N MaslovCardiology Research Institute, Tomsk National Research Medical Center of the RAS, Tomsk, Russia. maslov@cardio-tomsk.ru.ORCID https://orcid.org/0000-0002-6020-1598
Sergey V PopovCardiology Research Institute, Tomsk National Research Medical Center of the RAS, Tomsk, Russia.ORCID https://orcid.org/0000-0002-9050-4493
Alexandr V MukhomedzyanovCardiology Research Institute, Tomsk National Research Medical Center of the RAS, Tomsk, Russia.ORCID https://orcid.org/0000-0003-1808-556X
Ivan A DerkachevCardiology Research Institute, Tomsk National Research Medical Center of the RAS, Tomsk, Russia.ORCID https://orcid.org/0000-0003-1998-0873
Vyacheslav V RyabovCardiology Research Institute, Tomsk National Research Medical Center of the RAS, Tomsk, Russia.ORCID https://orcid.org/0000-0002-4358-7329
Alla A BoshchenkoCardiology Research Institute, Tomsk National Research Medical Center of the RAS, Tomsk, Russia.ORCID https://orcid.org/0000-0001-6009-0253
N Rajendra PrasadDepartment of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamilnadu, India.ORCID https://orcid.org/0000-0002-3937-8735
Galina Z SufianovaTyumen State Medical University, Tyumen, Russia.ORCID https://orcid.org/0000-0003-1291-0661
Maria S KhlestkinaTyumen State Medical University, Tyumen, Russia.ORCID https://orcid.org/0000-0002-5966-8916
Ilgiz GareevTyumen State Medical University, Tyumen, Russia.ORCID https://orcid.org/0000-0002-4965-0835
Tomsk National Research Medical Center · RUTyumen State Medical University · RUAnnamalai University · IN

Funding

Ministry of Science and Higher Education of the Russian Federation 122020300042-4
6 · The paper itself

Abstract

Ischemic and reperfusion injuries of the heart underlie the pathogenesis of acute myocardial infarction (AMI) and sudden cardiac death. The mortality rate is still high and is 5-7% in patients with ST-segment elevation myocardial infarction. The review is devoted to pharmacological approaches to limitation of ischemic and reperfusion injuries of the heart. The article analyzes experimental evidence and the clinical data on the effects of P2Y

Indexed as

Cardiac remodelingHeartIschemiaPurinergic P2YReperfusion

Identifiers

PMID36217596
PMCPMC9551227
OpenAlexW4304479318

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.